l General Information |
Product Name | 3BDO |
General description | 3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling pathway. It inhibits autophagy in HUVECs. |
Synonym | 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one |
Purity | ≥98.5%(HPLC) | CAS Number | 890405-51-3 |
Formula | C18H17NO5 | Molecular Weight | 327.33 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Colorless to Light brown Oil |
Solubility(25°C) | DMSO | ≥50mg/mL |
Ethanol | ≥45mg/mL |
Water | ≥5mg/mL |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |